Literature DB >> 15864136

Microsatellite polymorphisms in the epidermal growth factor receptor (EGFR) gene and the transforming growth factor-alpha (TGFA) gene and risk of oral cancer in Puerto Rico.

Daehee Kang1, Gloria Gridley, Wen-Yi Huang, Lawrence S Engel, Deborah M Winn, Linda M Brown, Eleuterio Bravo-Otero, Tianxia Wu, Scott R Diehl, Richard B Hayes.   

Abstract

OBJECTIVES AND METHODS: Risks of oral cancer related to a CA microsatellite repeat polymorphism in intron 1 of the epidermal growth factor receptor (EGFR) gene and a TaqI polymorphism in the transforming growth factor-alpha (TGFA) gene were evaluated in a population-based case-control study consisting of 157 cases and 149 controls recruited in Puerto Rico.
RESULTS: Carriers of > or = 16 CA repeats in EGFR showed a 1.9-fold increased risk for oral cancer (OR=1.9, 95% CI=1.0-3.5). Risks also tended to increase with decreasing number of alleles with > or = 16 CA repeats (P for trend=0.06). Our data suggested a non-significant reduction in risk for subjects heterozygous for the TGFA polymorphism (OR=0.6, 95% CI=0.2-1.3).
CONCLUSIONS: The EGFR-associated risk appeared to be independent of tobacco and alcohol use and may be restricted primarily to subjects who consumed low amounts of fresh fruits and vegetables (OR=5.9, 95%CI: 2.3-15.2). These data implicate dietary and molecular targets for oral cancer prevention.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15864136     DOI: 10.1097/01213011-200505000-00010

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN: 1744-6872            Impact factor:   2.089


  11 in total

1.  A novel environmental exposure index and its interaction with familial susceptibility on oral cancer in non-smokers and non-drinkers: a case-control study.

Authors:  Lingjun Yan; Fa Chen; Baochang He; Fengqiong Liu; Fangping Liu; Jiangfeng Huang; Junfeng Wu; Lisong Lin; Yu Qiu; Lin Cai
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-12-19       Impact factor: 2.503

Review 2.  Pharmacogenetic research activity in Central America and the Caribbean: a systematic review.

Authors:  Carolina Céspedes-Garro; María-Eugenia G Naranjo; Fernanda Rodrigues-Soares; Adrián LLerena; Jorge Duconge; Lazara K Montané-Jaime; Hilda Roblejo; Humberto Fariñas; María de Los A Campos; Ronald Ramírez; Víctor Serrano; Carmen I Villagrán; Eva M Peñas-LLedó
Journal:  Pharmacogenomics       Date:  2016-09-16       Impact factor: 2.533

3.  Epidermal growth factor receptor pathway polymorphisms and the prognosis of hepatocellular carcinoma.

Authors:  Wenjia Wang; Xiao-Pin Ma; Zhuqing Shi; Pengyin Zhang; Dong-Lin Ding; Hui-Xing Huang; Hexi Ge Saiyin; Tao-Yang Chen; Pei-Xin Lu; Neng-Jin Wang; Hongjie Yu; Jielin Sun; S Lilly Zheng; Long Yu; Jianfeng Xu; De-Ke Jiang
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

Review 4.  Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neck.

Authors:  Mark E Sharafinski; Robert L Ferris; Soldano Ferrone; Jennifer R Grandis
Journal:  Head Neck       Date:  2010-10       Impact factor: 3.147

5.  Identification of epidermal growth factor receptor (EGFR) genetic variants that modify risk for head and neck squamous cell carcinoma.

Authors:  Christopher Fung; Pei Zhou; Sonali Joyce; Kerry Trent; Jian-Min Yuan; Jennifer R Grandis; Joel L Weissfeld; Marjorie Romkes; Daniel E Weeks; Ann Marie Egloff
Journal:  Cancer Lett       Date:  2014-12-12       Impact factor: 8.679

6.  A novel EGFR mutation D1012H and polymorphism at exon 25 in Japanese lung cancer.

Authors:  Hidefumi Sasaki; Katsuhiro Okuda; Minoru Takada; Masaaki Kawahara; Naoto Kitahara; Akihide Matsumura; Keiji Iuchi; Tomoya Kawaguchi; Akihiko Kubo; Katsuhiko Endo; Osamu Kawano; Haruhiro Yukiue; Motoki Yano; Yoshitaka Fujii
Journal:  J Cancer Res Clin Oncol       Date:  2008-05-14       Impact factor: 4.553

7.  EGFR pathway polymorphisms and bladder cancer susceptibility and prognosis.

Authors:  Rebecca A Mason; Elaine V Morlock; Margaret R Karagas; Karl T Kelsey; Carmen J Marsit; Alan R Schned; Angeline S Andrew
Journal:  Carcinogenesis       Date:  2009-04-16       Impact factor: 4.944

8.  EGFR R497K polymorphism is a favorable prognostic factor for advanced lung cancer.

Authors:  Hidefumi Sasaki; Katsuhiro Okuda; Shigeki Shimizu; Minoru Takada; Masaaki Kawahara; Naoto Kitahara; Meinoshin Okumura; Akihide Matsumura; Keiji Iuchi; Tomoya Kawaguchi; Akihito Kubo; Osamu Kawano; Haruhiro Yukiue; Motoki Yano; Yoshitaka Fujii
Journal:  J Cancer Res Clin Oncol       Date:  2008-08-23       Impact factor: 4.553

9.  Epidermal growth factor receptor intron-1 CA repeat polymorphism on protein expression and clinical outcome in Taiwanese oral squamous cell carcinoma.

Authors:  Shiang-Fu Huang; Huei-Tzu Chien; Wen-Yu Chuang; Chih-Hsiung Lai; Sou-De Cheng; Chun-Ta Liao; Hung-Ming Wang
Journal:  Sci Rep       Date:  2017-07-10       Impact factor: 4.379

10.  Polymorphisms in the epidermal growth factor receptor gene and the risk of primary lung cancer: a case-control study.

Authors:  Jin Eun Choi; Sun Ha Park; Kyung Mee Kim; Won Kee Lee; Sin Kam; Sung Ick Cha; Chang Ho Kim; Young Mo Kang; Young-Chul Kim; Sung Beom Han; Tae Hoon Jung; Jae Yong Park
Journal:  BMC Cancer       Date:  2007-10-24       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.